PWM
GILD icon

Proathlete Wealth Management’s Gilead Sciences GILD Stock Holding History

Proathlete Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29K Hold
18
– – ﹤0.01% 206
2026
Q1 		$2.51K Hold
18
– – ﹤0.01% 201
2025
Q4 		$2.21K Buy
+18
New +$2.19K ﹤0.01% 222

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Proathlete Wealth Management's GILD Position: Q2 2026 in Review

Proathlete Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 18 shares worth $2.29K. The position accounts for ﹤0.01% of the portfolio, ranked #206.

Proathlete Wealth Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.51K in Q1 2026. 494 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Proathlete Wealth Management held 18 shares of Gilead Sciences worth $2.29K as of Q2 2026.
  • Proathlete Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Proathlete Wealth Management's portfolio in Q2 2026, its #206 holding.
  • Proathlete Wealth Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Proathlete Wealth Management's Gilead Sciences position peaked at $2.51K in Q1 2026.
  • 494 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Proathlete Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.